Arm Holdings plc Reports Results for the Fourth Quarter and Fiscal Year Ended 2026

Arm Holdings plc (NASDAQ: ARM), the company that is building the future of computing, has today published a letter to its shareholders containing the company's results for its fourth quarter and fiscal year ended March 31, 2026. The letter is available on its investor relations website ( https://investors.arm.com/financials/quarterly-annual-results ). The shareholder letter will also be furnished to the Securities and Exchange Commission (SEC) on a Form 6-K and will be available on the SEC website at http://www.sec.gov .

Arm will host an audio webcast to discuss its results at 14:00 PT / 17:00 ET / 22:00 BST today, May 6. The live webcast will be available at https://edge.media-server.com/mmc/p/parfpki9 and a replay will be at https://investors.arm.com/financials/quarterly-annual-results .

About Arm

Arm is the foundational platform for AI, delivering power-efficient, high-performance computing that touches 100 percent of the connected global population. To meet the insatiable demand for compute, Arm's platform spans core IP, advanced compute subsystems and purpose-built silicon, giving the world's leading technology companies the flexibility to design, build and deploy AI at scale. Arm has the world's largest computing ecosystem, including over 22 million developers, and together we are building the future of AI on Arm.

All information is provided "as is" and without warranty or representation. This document may be shared freely, attributed and unmodified. Arm is a registered trademark of Arm Limited (or its subsidiaries or affiliates). All brands or product names are the property of their respective holders. © 1995-2026 Arm Limited.

Media
Kristen Ray
Kristen.Ray@arm.com

Investors
Arm Investor Relations
Investor.Relations@arm.com

News Provided by Business Wire via QuoteMedia

ARM
The Conversation (0)
Miivo Engages Apaton Finance for Investor Awareness Services

Miivo Engages Apaton Finance for Investor Awareness Services

Miivo AI Inc. (TSXV: MIVO,OTC:MIVOF) (OTCQB: MIVOF) (FSE: L7S0) ("Miivo" or the "Company") is pleased to announce that it has engaged Apaton Finance GmbH ("Apaton Finance") to provide investor awareness, communications and marketing services to the Company, subject to applicable regulatory... Keep Reading...
Blue Jay Gold Announces Arrival of LithologIQ Hyperspectral Core Scanning System at the Steller Project

Blue Jay Gold Announces Arrival of LithologIQ Hyperspectral Core Scanning System at the Steller Project

Blue Jay Gold Corp. (TSXV: JAY,OTC:JAYGF) ("Blue Jay" or the "Company"), is pleased to announce that LithologIQ, a Montreal-based mineral technology company, has mobilized its hyperspectral core scanning system to the Company's 100%-owned Steller Gold Project ("Steller" or the "Project") in... Keep Reading...
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

KELOWNA, BC / ACCESS Newswire / June 25, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that dosing began on schedule on June 14th with Human Pilot Study #7 (GLP-1-H26-7) that is evaluating two oral... Keep Reading...
LaFleur Minerals Engages Maximus Strategic Consulting Inc. for Investor Relations and Marketing Services

LaFleur Minerals Engages Maximus Strategic Consulting Inc. for Investor Relations and Marketing Services

LaFleur Minerals Inc. (CSE: LFLR,OTC:LFLRF) (OTCQB: LRLRF) (FSE: 3WK0) ("LaFleur Minerals" or the "Company") announces that it has entered into a Content and Online Marketing Agreement dated June 16, 2026 (the "Agreement") with Maximus Strategic Consulting Inc. ("Maximus"), the owner and... Keep Reading...
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

Potentially Valuable Novel Compositions Being InvestigatedLexaria Also Receives Additional New Granted Patent KELOWNA, BC / ACCESS Newswire / June 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the following... Keep Reading...

Interactive Chart

Latest Press Releases

Related News